AMELIA MANCINI: Open Payments
NPI 1447848304 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 31 payments from 15 companies in 2025. Trend: 2023 $61 · 2024 $398 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $139 |
| PFIZER INC. | 5 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: Ozempic, SPRAVATO, NURTEC ODT, JARDIANCE, Veozah, Wegovy, TZIELD, Rybelsus.
Industry payments across MI — which companies pay providers there.
